{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:24:48Z","timestamp":1761110688772,"version":"3.37.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Qingdao Science and Technology Project","award":["23-2-8-smjk-14-nsh"],"award-info":[{"award-number":["23-2-8-smjk-14-nsh"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The use of human umbilical cord mesenchymal stem cells (UC-MSCs) has shown promise in improving the pathophysiological characteristics of rats with chronic obstructive pulmonary disease (COPD). However, more research is needed to understand the exact mechanism behind their therapeutic effects and their impact on lung microbiota.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>To investigate this, rats were randomly assigned to one of 3 groups: Control, COPD\u2005+\u2005vehicle, and COPD\u2005+\u2005UC-MSCs group. Lung function changes after UC-MSCs therapy were evaluated weekly for 6 weeks. Additionally, lactate dehydrogenase (LDH), TNF (tumor necrosis factor)-\u03b1, IL (interleukin)-6, and IL-1\u03b2 level in bronchoalveolar lavage fluid (BALF) were analyzed. Arterial blood gas and weight were recorded. Hematoxylin and eosin (HE) staining was used to examine lung pathology, while changes in the lung microbiota were evaluated through 16S rRNA sequencing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The administration of UC-MSCs in rats led to a progressive amelioration of COPD, as demonstrated by enhanced lung function and reduced inflammatory response. UC-MSCs treatment significantly altered the structure and diversity of the lung microbiota, effectively preventing microbiota dysbiosis. This was achieved by increasing the abundance of Bacteroidetes and reducing the levels of Proteobacteria. Additionally, treatment with UC-MSCs reduced the activation of pathways associated with COPD, including microbial metabolism, ABC transporters, and Quorum sensing. The group of UC-MSCs showed increased metabolic pathways, such as amino acid biosynthesis, purine metabolism, starch and sucrose metabolism, and biosynthesis of secondary metabolites, compared to the COPD group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The use of UC-MSCs was found to reduce inflammation and improve lung function in rats with COPD. The mechanism may be related to the lung microbiota, as UC-MSCs improved the communities of lung microbiota and regulated dysregulated metabolic pathways.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/stmcls\/sxae007","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T20:37:00Z","timestamp":1706128620000},"page":"346-359","source":"Crossref","is-referenced-by-count":3,"title":["Human Umbilical Cord Mesenchymal Stem Cells Improve Lung Function in Chronic Obstructive Pulmonary Disease Rat Model Through Regulating Lung Microbiota"],"prefix":"10.1093","volume":"42","author":[{"given":"Xiao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences , Qingdao , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences , Qingdao , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences , Qingdao , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianying","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences , Qingdao , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Qingdao Sino-Cell Biomedicine Co., Ltd , Qingdao , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences , Qingdao , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-0103","authenticated-orcid":false,"given":"Wei","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences , Qingdao , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"key":"2024041506064909500_CIT0001","first-page":"1931","article-title":"Chronic obstructive pulmonary disease","volume-title":"Lancet","author":"Rabe","year":"2017"},{"key":"2024041506064909500_CIT0002","first-page":"1633","article-title":"Inflammatory cells in the bronchial glands of smokers with chronic bronchitis","volume-title":"Am J Respir Crit Care Med","author":"Saetta","year":"1997"},{"key":"2024041506064909500_CIT0003","first-page":"P1","article-title":"Chronic obstructive pulmonary disease (COPD)","volume-title":"Am J Respir Crit Care Med","author":"Lareau","year":"2019"},{"key":"2024041506064909500_CIT0004","first-page":"85","article-title":"Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease","volume-title":"Ann N Y Acad Sci","author":"Chung","year":"2010"},{"key":"2024041506064909500_CIT0005","first-page":"1961","article-title":"Chronic obstructive pulmonary disease subpopulations and phenotyping","volume-title":"J Allergy Clin Immunol","author":"Segal","year":"2018"},{"key":"2024041506064909500_CIT0006","first-page":"1413","article-title":"MSCs: the sentinel and safe-guards of injury","volume-title":"J Cell Physiol","author":"Caplan","year":"2016"},{"key":"2024041506064909500_CIT0007","first-page":"2004216","article-title":"Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury","volume-title":"Eur Respir J","author":"Dos Santos","year":"2022"},{"key":"2024041506064909500_CIT0008","first-page":"99","article-title":"Anti-inflammatory, antioxidant, and antifibrotic effects of gingival-derived MSCs on bleomycin-induced pulmonary fibrosis in mice","volume-title":"Int J Mol Sci","author":"Wang","year":"2021"},{"key":"2024041506064909500_CIT0009","first-page":"31","article-title":"The potential of mesenchymal stem cell therapy for chronic lung disease","volume-title":"Expert Rev Respir Med","author":"Cruz","year":"2020"},{"key":"2024041506064909500_CIT0010","first-page":"3017","article-title":"Mesenchymal stromal cell therapy in COPD: from bench to bedside","volume-title":"Int J Chron Obstruct Pulmon Dis","author":"Antunes","year":"2017"},{"key":"2024041506064909500_CIT0011","first-page":"8733","article-title":"Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways","volume-title":"Sci Rep","author":"Gu","year":"2015"},{"issue":"2","key":"2024041506064909500_CIT0012","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3760\/cma.j.issn.0366-6999.2009.02.021","article-title":"Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury","volume":"122","author":"Cao","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"2024041506064909500_CIT0013","first-page":"1384","article-title":"Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow","volume-title":"Stem Cells","author":"Baksh","year":"2007"},{"key":"2024041506064909500_CIT0014","first-page":"548","article-title":"Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: from biological characteristics to therapeutic mechanisms","volume-title":"World J Stem Cells","author":"Yin","year":"2019"},{"key":"2024041506064909500_CIT0015","first-page":"713824","article-title":"Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in recovering from murine pulmonary emphysema under cigarette smoke exposure","volume-title":"Front Med (Lausanne)","author":"Chen","year":"2021"},{"key":"2024041506064909500_CIT0016","first-page":"8906","article-title":"Reduction of emphysema severity by human umbilical cord-derived mesenchymal stem cells in mice","volume-title":"Int J Mol Sci","author":"Laiman","year":"2022"},{"key":"2024041506064909500_CIT0017","first-page":"10872","article-title":"The lung microbiome during health and disease","volume-title":"Int J Mol Sci","author":"Yagi","year":"2021"},{"key":"2024041506064909500_CIT0018","first-page":"e150473","article-title":"The lung microbiome: progress and promise","volume-title":"J Clin Invest","author":"Whiteside","year":"2021"},{"key":"2024041506064909500_CIT0019","first-page":"183","article-title":"The sputum microbiome is distinct between COPD and health, independent of smoking history","volume-title":"Respir Res","author":"Haldar","year":"2020"},{"key":"2024041506064909500_CIT0020","first-page":"2027","article-title":"Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles","volume-title":"J Allergy Clin Immunol","author":"Ghebre","year":"2018"},{"key":"2024041506064909500_CIT0021","first-page":"438","article-title":"Host response to the lung microbiome in chronic obstructive pulmonary disease","volume-title":"Am J Respir Crit Care Med","author":"Sze","year":"2015"},{"key":"2024041506064909500_CIT0022","first-page":"2748","article-title":"Multi-omic meta-analysis identifies functional signatures of airway microbiome in chronic obstructive pulmonary disease","volume-title":"ISME J","author":"Wang","year":"2020"},{"key":"2024041506064909500_CIT0023","first-page":"475","article-title":"Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota","volume-title":"Stem Cell Res Ther","author":"Yang","year":"2022"},{"key":"2024041506064909500_CIT0024","first-page":"e13028","article-title":"Immunosuppressive effect of mesenchymal stem cells on lung and gut CD8(+) T cells in lipopolysaccharide-induced acute lung injury in mice","volume-title":"Cell Prolif","author":"Xu","year":"2021"},{"key":"2024041506064909500_CIT0025","first-page":"6500","article-title":"Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus","volume-title":"Theranostics","author":"Lv","year":"2020"},{"key":"2024041506064909500_CIT0026","first-page":"712139","article-title":"MSCs therapy reverse the gut microbiota in hypoxia-induced pulmonary hypertension mice","volume-title":"Front Physiol","author":"Luo","year":"2021"},{"key":"2024041506064909500_CIT0027","first-page":"74","article-title":"Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation","volume-title":"Am J Respir Crit Care Med","author":"Birrell","year":"2005"},{"key":"2024041506064909500_CIT0028","first-page":"248","article-title":"Effect of nartograstim, a recombinant human granulocyte colony-stimulating factor on elastase-induced emphysema in rats","volume-title":"Arzneimittelforschung","author":"Yoshimatsu","year":"2009"},{"key":"2024041506064909500_CIT0029","first-page":"36","article-title":"Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase","volume-title":"Stem Cell Res Ther","author":"Zhang","year":"2018"},{"key":"2024041506064909500_CIT0030","first-page":"62","article-title":"Anti-fibrotic effect of intravenous umbilical cord-derived mesenchymal stem cells (UC-MSCs) injection in experimental rats induced liver fibrosis","volume-title":"Med Glas (Zenica)","author":"Sungkar","year":"2021"},{"key":"2024041506064909500_CIT0031","first-page":"117","article-title":"Repeated assessment of cardiovascular and respiratory functions using combined telemetry and whole-body plethysmography in the rat","volume-title":"J Pharmacol Toxicol Methods","author":"Delaunois","year":"2009"},{"key":"2024041506064909500_CIT0032","first-page":"BSR20171636","article-title":"Treatment with eucalyptol mitigates cigarette smoke-induced lung injury through suppressing ICAM-1 gene expression","volume-title":"Biosci Rep","author":"Yu","year":"2018"},{"key":"2024041506064909500_CIT0033","first-page":"1479973119838280","article-title":"Mortality and vertebral fracture risk associated with long-term oral steroid use in patients with chronic obstructive pulmonary disease: A systemic review and meta-analysis","volume-title":"Chron Respir Dis","author":"Chang","year":"2019"},{"key":"2024041506064909500_CIT0034","first-page":"739","article-title":"Corticosteroids in chronic obstructive pulmonary disease. Clinical benefits and risks","volume-title":"Clin Chest Med","author":"McEvoy","year":"2000"},{"key":"2024041506064909500_CIT0035","first-page":"e0487","article-title":"Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD)","volume-title":"Medicine (Baltim)","author":"Gadre","year":"2018"},{"key":"2024041506064909500_CIT0036","first-page":"60","article-title":"Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study","volume-title":"Stem Cell Res Ther","author":"Le Thi Bich","year":"2020"},{"key":"2024041506064909500_CIT0037","first-page":"290","article-title":"Heat shock preconditioning mesenchymal stem cells attenuate acute lung injury via reducing NLRP3 inflammasome activation in macrophages","volume-title":"Stem Cell Res Ther","author":"Lv","year":"2021"},{"key":"2024041506064909500_CIT0038","first-page":"341","article-title":"Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2","volume-title":"EBioMedicine","author":"Zhang","year":"2019"},{"key":"2024041506064909500_CIT0039","first-page":"e20210615","article-title":"Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung","volume-title":"J Exp Med","author":"Pisu","year":"2021"},{"key":"2024041506064909500_CIT0040","first-page":"1703","article-title":"Modulation of gut microbiome composition and function in experimental colitis treated with sulfasalazine","volume-title":"Front Microbiol","author":"Zheng","year":"2017"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stmcls\/advance-article-pdf\/doi\/10.1093\/stmcls\/sxae007\/56820814\/sxae007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/42\/4\/346\/57189720\/sxae007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/42\/4\/346\/57189720\/sxae007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T06:07:09Z","timestamp":1713161229000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/42\/4\/346\/7590577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,1,27]]},"published-print":{"date-parts":[[2024,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/stmcls\/sxae007","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"type":"print","value":"1066-5099"},{"type":"electronic","value":"1549-4918"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,1,27]]}}}